Here's Won't Touch Teva: Why I Pass on the Generic Giant
Teva Pharmaceuticals sits at a crossroads of debt, generics, and a shifting pricing landscape. Here's why I won't tou...
Want to know ways to sell products online quickly? Discover effective strategies that can help you generate sales fast.
21,381 articlesTeva Pharmaceuticals sits at a crossroads of debt, generics, and a shifting pricing landscape. Here's why I won't tou...
Elon Musk’s clash with OpenAI doubles as a bid to launch xAI, with Tesla financing and strategic partnerships setting...
July fans risk-off mood across markets, and crypto is no exception. Bitcoin slips from recent highs as traders weigh ...
Broadcom is signaling strong momentum in AI infrastructure with a growing portfolio of custom chips and a robust back...
A once-tiny energy startup sparked a rally after finally showing a profitable revenue stream through an acquired subs...
Apple files a federal trade secret suit against OpenAI, arguing a pattern of theft to protect its hardware lead. The ...
Goldman Sachs forecasts a path to $100 oil as geopolitical tensions and supply discipline tighten markets. Meanwhile,...
Spot Bitcoin ETFs are drawing record flows in 2026, with IBIT and FBTC leading liquidity. Here’s how to pick which bi...
The White House announced 50% tariffs on targeted Canadian imports, including autos, dairy, and alcohol, effective mi...
Microsoft is doubling down on AI. This article lays out scenarios, risks, and concrete steps to understand where will...
A morning surge in AeroVironment stock popped today after reports of potential U.S. drone subsidies. This guide unpac...
As KVHI gears up for the 2025 earnings call, investors should focus on revenue drivers, margins, and long-term strate...